IOLCP

** Shares of IOL Chemicals IOLC.NS rise 5% to 343.7 rupees

** Co receives certificate of suitability for its API product quetiapine fumarate from the European Directorate for Quality of Medicines and Health Care

** This allows co to export the product to European and other countries that accept the certification, co says

** More than 352,000 shares change hands, 1.8x its 30-day avg

** Stock up about 8% so far this week

(Reporting by Ashna Teresa Britto in Bengaluru)

(([email protected] ; ( +91 8078332441))

** IOL Chemicals IOLC.NS rises ~3% to 401.25 rupees

** Pharma and chemical products maker gets European drug regulator's certificate of suitability for a drug used to treat inflammatory bowel disease

** IOLC now will be able to export the drug, Mesalazine, to European countries

** Global market size for Mesalazine drug has been estimated to be worth ~$162 million in 2023 and projected to be $224 million by 2030 - pharma market research firm QY Research

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

Jan 17 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• EDQM ISSUED CEP CERTIFICATE FOR MESALAZINE

Further company coverage: IOLC.NS

(([email protected];;))

** Shares of IOL Chemicals IOLC.NS up 4.3% at 426 rupees

** Co on Friday approved share split in 1:5 ratio

** Stock down 7.6% YTD

(Reporting by Sethuraman NR in Bengaluru)

(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))

Dec 27 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS LTD - APPROVES SHARE SPLIT 1:5

Source text: ID:nBSE1LnHzX

Further company coverage: IOLC.NS

(([email protected];))

** Shares of IOL Chemicals and Pharmaceuticals Ltd IOLC.NS rise as much as 7.6% to 436.7 rupees

** Chemical products maker says it will consider sub-division of shares in board meeting on Dec. 27

** Stock on track to gain for 4th straight week, up 3.6% so far this week

** More than 1.9 mln shares traded as of 10:48 a.m. IST, 6.6x their 30-day moving avg

** IOLC last up 6%, trimming YTD losses to 7.1%

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

Dec 18 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• TO CONSIDER SHARE SPLIT

Source text: ID:nBSE8X4YGh

Further company coverage: IOLC.NS

(([email protected];;))

Sept 18 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS - VIKAS VIJ TENDERED RESIGNATION AS CEO

Source text for Eikon: ID:nBSE7DR5qV

Further company coverage: IOLC.NS

(([email protected];))

Aug 9 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS JUNE-QUARTER CONSOL PROFIT 299.7 MILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 5.02 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: IOLC.NS

(([email protected];))

** Shares of IOL Chemicals and Pharmaceuticals IOLC.NS rise 4.2% to 413.64 rupees apiece

** IOLC on course to snap a six-session losing streak

** The company gets certificate of suitability from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its blood pressure drug Valsartan

** Certification to help IOLC to export Valsartan in European and other CEP accepting countries

** Shares of IOLC down 11% in 2024 so far

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463;))

July 23 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• EDQM ISSUED CERTIFICATE OF SUITABILITY FOR “VALSARTAN”

Source text for Eikon: ID:nNSE39pWq5

Further company coverage: IOLC.NS

(([email protected];;))

** Shares of India's IOL Chemicals and Pharmaceuticals IOLC.NS up 7.7% at 441 rupees after rising as much as 9.7% in early trade

** Co gets nod from Chinese drug regulator to export cholesterol drug Fenofibrate to the country

** Trading vols 5.4x 30-day avg in early trade

** YTD, stock has fallen ~5%

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

July 1 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS - NMPA CHINA APPROVES FENOFIBRATE MANUFACTURED BY CO

• IOL CHEMICALS AND PHARMACEUTICALS - APPROVAL TO ENABLE CO TO EXPORT FENOFIBRATE API IN CHINA MARKET

Source text for Eikon: ID:nNSEb5DQwz

Further company coverage: IOLC.NS

(([email protected];))

** Shares of India's IOL Chemicals and Pharmaceuticals IOLC.NS up 4.2% after jumping as much as 6.3% earlier in the session

** Pharmaceuticals and chemicals maker gets nods from European Directorate for the Quality of Medicines & Health Care (EDQM) to export two drugs

** Trading vols 7.6x 30-day avg in busiest session since March 19

** YTD stock has fallen ~15% after climbing 24% in 2023

(Reporting by Hritam Mukherjee in Bengaluru)

(([email protected];))

June 11 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• EDQM ISSUED CEP CERTIFICATE FOR “ALLOPURINOL”

Source text for Eikon: ID:nNSE8llTVf

Further company coverage: IOLC.NS

(([email protected];;))

** Shares of IOL Chemicals and Pharmaceuticals IOLC.NS down 2.4% at 367.70 rupees; it fell as much as 4.2% earlier in the session

** Active pharmaceutical ingredient and speciality chemicals maker on Tuesday reported 56.8% Y/Y fall in Q4 profit while rev from ops fell 14.2% Y/Y

** Co's segmental revenue from chemical and pharmaceutical businesses fell 9.7% and 19.7%, respectively

** Last week, larger peer by market capitalisation SRF SRFL.NS too posted a near 25% fall in Q4 profit

** Trading vol 2.2x 30-day daily avg

** IOLC shares fell 22% in March quarter vs 3.3% rise by SRFL shares

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

May 14 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS MARCH-QUARTER PROFIT 281.9 MILLION RUPEES VERSUS 652.7 MILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS MARCH-QUARTER REVENUE FROM OPERATIONS 5.04 BILLION RUPEES VERSUS 5.87 BILLION RUPEES

Source text for Eikon: ID:nNSE7yR5B6

Further company coverage: IOLC.NS

(([email protected];))

May 3 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• RECEIVED CERTIFICATE OF GOOD MANUFACTURING PRACTICES FROM BRAZILIAN HEALTH REGULATORY AGENCY

• RECEIVED CERTIFICATE FOR ALL 10 APIS MANUFACTURING UNITS SITUATED AT BARNALA

Source text for Eikon: ID:nBSE1C1TqH

Further company coverage: IOLC.NS

(([email protected];;))

April 4 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS LTD- EDQM ISSUED A CERTIFICATE OF SUITABILITY FOR GABAPENTIN

Source text for Eikon: ID:nBSE3zs2tj

Further company coverage: IOLC.NS

(([email protected];;))

** Shares of IOL Chemicals and Pharmaceuticals IOLC.NS rise as much as 13.3% to 410 rupees

** Co says has completed Brazilian Health Regulatory Agency's manufacturing practices audit without any observation at all API manufacturing units at Barnala, Punjab

** More than 3.2 mln shares traded as of 10:08 a.m. IST, most active day yet since Sept. 14, 2023

** IOLC is off ~0.2% so far this month; down 12.3% YTD

(Reporting by Meenakshi Maidas in Bengaluru)

(([email protected];))

March 18 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• COMPLETED BRAZILIAN HEALTH REGULATORY AGENCY (ANVISA) GMP AUDIT

• COMPLETED ANVISA GMP AUDIT OF 10 APIS MANUFACTURING UNITS SITUATED AT BARNALA, PUNJAB

• AUDIT COMPLETED WITHOUT ANY OBSERVATION

Source text for Eikon: ID:nBSE9lcv9b

Further company coverage: IOLC.NS

(([email protected];))

Feb 19 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• CDE, CHINA APPROVED "METFORMIN HYDROCHLORIDE"

• ENABLE COMPANY TO EXPORT METFORMIN HYDROCHLORIDE IN CHINA MARKET

Source text for Eikon: ID:nBSE5CqhZb

Further company coverage: IOLC.NS

(([email protected];))

Feb 6 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS DEC-QUARTER CONSOL PROFIT 230.8 MILLION RUPEES VERSUS PROFIT 237.8 MILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 5.20 BILLION RUPEES VERSUS 5.23 BILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS INTERIM DIVIDEND 5 RUPEES PER SHR

Source text for Eikon: ID:nBSE2X7nDR

Further company coverage: IOLC.NS

(([email protected];))

Nov 8 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• IOL CHEMICALS AND PHARMACEUTICALS SEPT-QUARTER CONSOL PROFIT 378.7 MILLION RUPEES VERSUS 159.1 MILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 5.45 BILLION RUPEES VERSUS 5.41 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: IOLC.NS

(([email protected];))

Aug 9 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• INDIA'S IOL CHEMICALS AND PHARMACEUTICALS JUNE-QUARTER CONSOL PROFIT 458.6 MILLION RUPEES VERSUS PROFIT 346.7 MILLION RUPEES

• IOL CHEMICALS AND PHARMACEUTICALS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 5.63 BILLION RUPEES VERSUS 5.65 BILLION RUPEES

Source text for Eikon: ID:nBSEbcPpTY

Further company coverage: IOLC.NS

(([email protected];;))

June 12 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• COMMENCED ITS PLANT FOR ACETIC ANHYDRIDE WITH EFFECT FROM JUNE 11

Source text for Eikon: ID:nBSE5HNjTY

Further company coverage: IOLC.NS

(([email protected];))

** IOL Chemicals and Pharmaceuticals Ltd IOLC.NS up nearly 3% at 404.50 rupees, set to snap a 3-day losing streak

** Brokerage Antique Stock Broking reiterates "buy" and raises PT to 510 rupees from 440 rupees after IOL's Q4 results

** Two weeks back, IOL reported 3% Q4 rev growth, driven by margin recovery in chemicals segment and favourable product mix

** Antique Stock Broking raises its Fy25 rev and EPS estimates by 4% and 16%, respectively, betting on pharma segment

** Expects pharma rev to grow at 18% CAGR over the next three years vs overall revenue CAGR of 9%

** Stock's gains helps it to swing to 1.5% growth for May, after a 41% surge in April, its best month since July 2020

(Reporting by Bharath Rajeswaran in Bengaluru)

(([email protected]; +91 9769003463))

May 8 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• RECEIVES CEP FOR PARACETAMOL TO EXPORT IN EUROPEAN MARKET

Source text for Eikon: ID:nBSE3qBzDT

Further company coverage: IOLC.NS

(([email protected];;))

April 28 (Reuters) - IOL Chemicals and Pharmaceuticals Ltd IOLC.NS:

• MARCH-QUARTER PROFIT 652.7 MILLION RUPEES VERSUS 277.5 MILLION RUPEES

• RE-APPOINTS VARINDER GUPTA AS MANAGING DIRECTOR

• MARCH-QUARTER REVENUE FROM OPERATIONS 5.87 BILLION RUPEES VERSUS 5.72 BILLION RUPEES

Further company coverage: IOLC.NS

(([email protected];))